These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1283733

  • 1. Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan.
    Bhakta DR, Leader I, Jacobson R, Robinson-Dunn B, Honicky RE, Kumar A.
    Chemotherapy; 1992; 38(5):319-23. PubMed ID: 1283733
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial activity of new antibiotics against bacterial isolates from a community hospital.
    Dyke JW, Angones D, Bhakta D, Tenjarla G, Kumar A.
    Chemotherapy; 1993; 39(5):315-21. PubMed ID: 8370322
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM, Brown SD.
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [Abstract] [Full Text] [Related]

  • 4. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A, Hay MB, Maier GA, Dyke JW.
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [Abstract] [Full Text] [Related]

  • 5. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL, Smith RP, Ritz W.
    Chemotherapy; 1994 Nov; 40(6):391-8. PubMed ID: 7842822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
    Rajyaguru JM, Muszynski MJ.
    J Antimicrob Chemother; 1997 Sep; 40(3):345-51. PubMed ID: 9338485
    [Abstract] [Full Text] [Related]

  • 8. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF, McElnay JC, Elborn JS, Tunney MM.
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa.
    Cabezudo I, Pfaller M, Bale M, Wenzel R.
    Diagn Microbiol Infect Dis; 1989 Nov; 12(4):337-41. PubMed ID: 2512048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
    Akaniro JC, Vidaurre CE, Stutman HR, Marks MI.
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1880-4. PubMed ID: 2127170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergy of new C-3 substituted cephalosporins and tobramycin against Pseudomonas aeruginosa and Pseudomonas cepacia.
    Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1989 Oct; 12(4):343-9. PubMed ID: 2512049
    [Abstract] [Full Text] [Related]

  • 16. Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.
    Bosso JA, Saxon BA, Matsen JM.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):783-4. PubMed ID: 1906264
    [Abstract] [Full Text] [Related]

  • 17. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M.
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.
    Díez-Aguilar M, Ekkelenkamp M, Morosini MI, Merino I, de Dios Caballero J, Jones M, van Westreenen M, Tunney MM, Cantón R, Fluit AC.
    Int J Antimicrob Agents; 2019 Jan; 53(1):84-88. PubMed ID: 30240837
    [Abstract] [Full Text] [Related]

  • 20. [In vitro activity of fluoroquinolones and oral beta lactam antibiotics against clinical isolates of Escherichia coli].
    Gómez-Martínez J, Marco F, Mensa J, Espasa M, Martínez JA, Jiménez de Anta MT.
    Rev Esp Quimioter; 1999 Mar; 12(1):54-7. PubMed ID: 10209063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.